Physician profile
Ronald E Kimmel
NPI 1649257338
$21,609.75
in general payments reported to CMS, 2019-2025
89 companies · $3,827 in 2025
The $3,827 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $2,831 · 2021: $4,076 · 2022: $3,163 · 2023: $3,152 · 2024: $3,849 · 2025: $3,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $5.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,822.45 |
| Education | $5.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $2,288.97 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,889.29 | 2019-2025 | |
| Abbott Laboratories | $1,840.26 | 2020-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,591.64 | 2019-2025 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $1,515.59 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $1,156.98 | 2020-2025 | Airsupra, Breztri, Bevespi Aerosphere |
| Amgen INC. | $1,127.25 | 2020-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $804.12 | 2019-2025 | |
| Pfizer INC. | $703.41 | 2019-2025 | |
| Novo Nordisk INC | $651.31 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $555.83 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $419.53 | 2023-2025 | Cologuard Collection Kit |
| Mallinckrodt Hospital Products INC. | $418.29 | 2020-2025 | Acthar |
| Corcept Therapeutics | $404.77 | 2019-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $396.98 | 2019-2025 | Xifaxan |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $361.91 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $280.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $264.74 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $251.76 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $248.82 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $240.54 | 2022-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $186.88 | 2022-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $185.72 | 2021-2025 | |
| Dexcom, INC. | $178.05 | 2021-2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $176.76 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Actelion Pharmaceuticals US, INC. | $175.85 | 2024-2025 | Opsumit, Uptravi |
| Neurocrine Biosciences, INC. | $161.06 | 2024-2025 | |
| Amryt Pharma Holdings Ltd | $156.23 | 2022-2023 | Mycapssa |
| Takeda Pharmaceuticals U.S.A., INC. | $154.00 | 2020-2025 | Glassia |
| Cequr Corporation | $149.67 | 2022-2025 | Cequr Simplicity |
| Amarin Pharma, INC. | $148.09 | 2020-2022 | |
| Harmony Biosciences LLC | $139.16 | 2023-2025 | Wakix |
| Radius Health, INC. | $118.31 | 2020-2025 | Tymlos |
| Teleflex LLC | $112.79 | 2022-2023 | Urolift |
| Medtronic, INC. | $93.47 | 2021-2025 | Interstim, Minimed 780g |
| Insulet Corporation | $91.75 | 2023-2025 | Omnipod |
| Almatica Pharma LLC | $88.62 | 2022-2025 | Teriparatide |
| Regeneron Healthcare Solutions, INC. | $86.32 | 2022-2024 | Dupixent |
| Chiesi USA, INC. | $81.69 | 2024-2025 | Mycapssa |
| Mylan Specialty L.P. | $80.63 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $79.50 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $76.13 | 2022-2024 | |
| Lundbeck LLC | $75.21 | 2024-2025 | Rexulti |
| Allergan, INC. | $68.60 | 2020 | |
| Verona Pharma, INC. | $63.07 | 2025 | Ohtuvayre |
| Alexion Pharmaceuticals, INC. | $61.96 | 2023-2024 | Strensiq |
| Becton, Dickinson and Company | $54.27 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $48.94 | 2025 | Eliquis |
| Eisai INC. | $47.97 | 2020-2021 | |
| Shield Therapeutics INC | $45.98 | 2025 | |
| Mannkind Corporation | $44.04 | 2025 | |
| Acerus Pharmaceuticals Corporation | $41.78 | 2021-2022 | |
| Shire North American Group INC | $41.22 | 2019 | |
| Axsome Therapeutics, INC. | $39.79 | 2025 | Auvelity |
| Indivior INC. | $38.76 | 2025 | Sublocade |
| Alvogen INC | $38.41 | 2023-2025 | Teriparatide |
| Inspire Medical Systems, INC. | $37.83 | 2024 | Inspire |
| Antares Pharma, INC. | $36.88 | 2023 | Nocdurna, Xyosted, Tlando |
| Seqirus USA INC | $36.07 | 2025 | Fluad, Flucelvax |
| Nabriva Therapeutics, Plc | $35.18 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $34.13 | 2021-2025 | Isturisa |
| Lexicon Pharmaceuticals, INC. | $33.64 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $31.64 | 2019-2020 | |
| Viatris Specialty LLC | $30.57 | 2025 | Yupelri |
| Tandem Diabetes Care, INC. | $29.05 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Axonics, INC. | $26.82 | 2022 | |
| Ibsa Pharma INC. | $24.77 | 2023 | Tirosint, Licart |
| Madrigal Pharmaceuticals | $24.60 | 2025 | Rezdiffra |
| Intra-Sana Laboratories | $24.37 | 2025 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Philips North America LLC | $23.03 | 2021 | |
| Ascendis Pharma Endocrinology INC | $21.19 | 2025 | Yorvipath |
| Phathom Pharmaceuticals, INC. | $21.04 | 2024 | Voquezna |
| Biogen, INC. | $20.86 | 2025 | Skyclarys |
| Sequel Med Tech, LLC | $20.75 | 2025 | Twiist |
| Pulmonx Corporation | $20.57 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Zealand Pharma US, INC. | $20.46 | 2021 | |
| Insmed, INC. | $20.41 | 2024 | Arikayce |
| Mallinckrodt Enterprises LLC | $19.02 | 2019 | |
| Gilead Sciences, INC. | $18.65 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $18.06 | 2025 | Imcivree |
| Kyowa Kirin, INC. | $17.78 | 2024 | Crysvita |
| Qiagen, LLC | $16.95 | 2021 | |
| Grifols USA, LLC | $16.20 | 2021 | |
| Aytu Biopharma, INC. | $15.71 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.62 | 2025 | Nuzyra |
| Ipsen Biopharmaceuticals, INC | $15.35 | 2020 | |
| Companion Medical, INC. | $15.16 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.42 | 2021 | |
| Progenics Pharmaceuticals, INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
Freestyle Libre 3 $1,148Vraylar $1,138Mounjaro $596Jardiance $565Trelegy Ellipta $510Ozempic $455Cologuard Collection Kit $395Rybelsus $391Airsupra $328Rexulti $297Zepbound $288Veozah $269Arexvy $249Synthroid $236Eliquis $216Xifaxan $201Prolia $185Shingrix $176Opsumit $176Nurtec Odt $167Caplyta $167Evenity $160Breztri $159Mycapssa $153Acthar $147Wakix $139Glassia $136Ubrelvy $135Cequr Simplicity $123Recorlev $123Prevnar 20 $115Nucala $110Toujeo $107Uptravi $107Tymlos $104Tzield $99.26Teriparatide $95.69Omnipod $91.75Ingrezza $88.18Qulipta $87.71Tepezza $85.38Repatha $84.37Bevespi Aerosphere $79.84Dupixent $72.20Dexcom G6 Transmitter $68.53Ohtuvayre $63.07Korlym $63.00Abrysvo $62.45Strensiq $61.96Otezla $60.19Urolift $57.62Tirosint $49.54Paxlovid $46.81Accrufer $45.98Afrezza $44.04Kerendia $40.49Auvelity $39.79Sublocade $38.76Leqvio $38.23Entresto $38.23Inspire $37.83Xyosted $36.88Tlando $36.88Nocdurna $36.88Flucelvax $36.07Fluad $36.07Inpefa $33.64Yupelri $30.57T:Slim X2 Insulin Pump With Control-Iq $29.05Crenessity $28.21Isturisa $24.84Licart $24.77Gvoke Hypopen $24.65Rezdiffra $24.60Reltone 200 Mg $24.37Glycate $24.37Reltone 400 Mg $24.37Emgality $23.38Wegovy $22.50Comirnaty $22.00Yorvipath $21.19Voquezna $21.04Vyndamax $20.90Skyclarys $20.86Twiist $20.75Zephyr Delivery Catheter $20.57Zephyr Endobronchial Valve $20.57Pulmonx Chartis Tablet Console $20.57Chartis Catheter $20.57Arikayce $20.41Interstim $20.29Synjardy $20.27Soliqua 100/33 $18.59Minimed 780g $18.15Imcivree $18.06Crysvita $17.78Lyumjev $16.22Baqsimi $16.22Nuzyra $15.62Linzess $14.48
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Kimmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.